32116751|t|Dexmedetomidine Exerted Anti-arrhythmic Effects in Rat With Ischemic Cardiomyopathy via Upregulation of Connexin 43 and Reduction of Fibrosis and Inflammation.
32116751|a|BACKGROUND: Persistent myocardial ischemia post-myocardial infarction can lead to fatal ventricular arrhythmias such as ventricular tachycardia and fibrillation, both of which carry high mortality rates. Dexmedetomidine (Dex) is a highly selective alpha2-agonist used in surgery for congenital cardiac disease because of its antiarrhythmic properties. Dex has previously been reported to prevent or terminate various arrhythmias. The purpose of the present study was to determine the anti-arrhythmic properties of Dex in the context of ischemic cardiomyopathy (ICM) after myocardial infarction. METHODS AND RESULTS: We randomly allocated 48 rats with ICM, created by persistent ligation of the left anterior descending artery for 4 weeks, into six groups: Sham (n = 8), Sham + BML (n = 8), ICM (n = 8), ICM + BML (n = 8), ICM + Dex (n = 8), and ICM + Dex + BML (n = 8). Treatments started after ICM was confirmed (the day after echocardiographic measurement) and continued for 4 weeks (inject intraperitoneally, daily). Dex inhibited the generation of collagens, cytokines, and other inflammatory mediators in rats with ICM via the suppression of NF-kappaB activation and increased the distribution of connexin 43 (Cx43) via phosphorylation of adenosine 5'-monophosphate-activated protein kinase (AMPK). Dex reduced the occurrence of spontaneous ventricular arrhythmias (ventricular premature beat or ventricular tachycardia), decreased the inducibility quotient of ventricular arrhythmias induced by PES, and partly improved cardiac contraction. The AMPK antagonist BML-275 dihydrochloride (BML) partly weakened the cardioprotective effect of Dex. CONCLUSION: Dex conferred anti-arrhythmic effects in the context of ICM via upregulation of Cx43 and suppression of inflammation and fibrosis. The anti-arrhythmic and anti-inflammatory properties of Dex may be mediated by phosphorylation of AMPK and subsequent suppression of NF-kappaB activation.
32116751	0	15	Dexmedetomidine	Chemical	MESH:D020927
32116751	29	39	arrhythmic	Disease	OMIM:212500
32116751	51	54	Rat	Species	10116
32116751	60	83	Ischemic Cardiomyopathy	Disease	MESH:D009202
32116751	104	115	Connexin 43	Gene	24392
32116751	133	141	Fibrosis	Disease	MESH:D005355
32116751	146	158	Inflammation	Disease	MESH:D007249
32116751	183	202	myocardial ischemia	Disease	MESH:D017202
32116751	208	229	myocardial infarction	Disease	MESH:D009203
32116751	248	271	ventricular arrhythmias	Disease	MESH:D001145
32116751	280	320	ventricular tachycardia and fibrillation	Disease	MESH:D014693
32116751	364	379	Dexmedetomidine	Chemical	MESH:D020927
32116751	381	384	Dex	Chemical	MESH:D020927
32116751	454	469	cardiac disease	Disease	MESH:D006331
32116751	512	515	Dex	Chemical	MESH:D020927
32116751	577	588	arrhythmias	Disease	MESH:D001145
32116751	649	659	arrhythmic	Disease	OMIM:212500
32116751	674	677	Dex	Chemical	MESH:D020927
32116751	696	719	ischemic cardiomyopathy	Disease	MESH:D009202
32116751	721	724	ICM	Disease	MESH:D009202
32116751	732	753	myocardial infarction	Disease	MESH:D009203
32116751	801	805	rats	Species	10116
32116751	811	814	ICM	Disease	MESH:D009202
32116751	937	940	BML	Chemical	-
32116751	950	953	ICM	Disease	MESH:D009202
32116751	963	966	ICM	Disease	MESH:D009202
32116751	969	972	BML	Chemical	-
32116751	982	985	ICM	Disease	MESH:D009202
32116751	988	991	Dex	Chemical	MESH:D020927
32116751	1005	1008	ICM	Disease	MESH:D009202
32116751	1011	1014	Dex	Chemical	MESH:D020927
32116751	1017	1020	BML	Chemical	-
32116751	1055	1058	ICM	Disease	MESH:D009202
32116751	1180	1183	Dex	Chemical	MESH:D020927
32116751	1244	1256	inflammatory	Disease	MESH:D007249
32116751	1270	1274	rats	Species	10116
32116751	1280	1283	ICM	Disease	MESH:D009202
32116751	1362	1373	connexin 43	Gene	24392
32116751	1375	1379	Cx43	Gene	24392
32116751	1404	1455	adenosine 5'-monophosphate-activated protein kinase	Gene	78975
32116751	1457	1461	AMPK	Gene	78975
32116751	1464	1467	Dex	Chemical	MESH:D020927
32116751	1506	1529	ventricular arrhythmias	Disease	MESH:D001145
32116751	1531	1557	ventricular premature beat	Disease	MESH:D018879
32116751	1561	1584	ventricular tachycardia	Disease	MESH:D017180
32116751	1626	1649	ventricular arrhythmias	Disease	MESH:D001145
32116751	1661	1664	PES	Disease	OMIM:192950
32116751	1686	1705	cardiac contraction	Disease	MESH:D006331
32116751	1711	1715	AMPK	Gene	78975
32116751	1727	1750	BML-275 dihydrochloride	Chemical	-
32116751	1752	1755	BML	Chemical	-
32116751	1804	1807	Dex	Chemical	MESH:D020927
32116751	1821	1824	Dex	Chemical	MESH:D020927
32116751	1840	1850	arrhythmic	Disease	OMIM:212500
32116751	1877	1880	ICM	Disease	MESH:D009202
32116751	1901	1905	Cx43	Gene	24392
32116751	1925	1937	inflammation	Disease	MESH:D007249
32116751	1942	1950	fibrosis	Disease	MESH:D005355
32116751	1961	1971	arrhythmic	Disease	OMIM:212500
32116751	1981	1993	inflammatory	Disease	MESH:D007249
32116751	2008	2011	Dex	Chemical	MESH:D020927
32116751	2050	2054	AMPK	Gene	78975
32116751	Association	MESH:D007249	78975
32116751	Association	24392	78975
32116751	Negative_Correlation	MESH:D020927	MESH:D017180
32116751	Negative_Correlation	MESH:D020927	MESH:D009202
32116751	Association	OMIM:212500	78975
32116751	Negative_Correlation	MESH:D020927	OMIM:192950
32116751	Association	MESH:D020927	MESH:D006331
32116751	Negative_Correlation	MESH:D020927	MESH:D018879
32116751	Association	MESH:D020927	78975
32116751	Negative_Correlation	MESH:D020927	MESH:D001145
32116751	Negative_Correlation	MESH:D020927	MESH:D007249
32116751	Negative_Correlation	MESH:D020927	MESH:D005355
32116751	Negative_Correlation	MESH:D020927	OMIM:212500
32116751	Association	OMIM:212500	24392
32116751	Positive_Correlation	MESH:D020927	24392

